Upgrade to SI Premium - Free Trial

Omnicell (OMCL) PT Lowered to $45 at Piper Sandler

August 3, 2026 8:15 AM
Piper Sandler analyst Jessica Tassan lowered the price target on Omnicell (NASDAQ: OMCL) to $45.00 (from $55.00) while maintaining a Overweight rating.

Categories

Analyst PT Change